Clinical Trial Update: Safety and Efficacy of Autologous Bone Marrow Mononuclear Cells in Patients With Severe Critical Limb Ischemia [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports safety and efficacy results for autologous bone marrow mononuclear cells used to treat severe critical limb ischemia in a Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• Autologous bone marrow mononuclear cells (bone marrow mononuclear cells)

Snippet

Sponsor: TotipotentSC Scientific Product Pvt. Ltd. | Conditions: Critical Limb Ischemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-11-18